Previous 10 | Next 10 |
Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2022 Earnings Conference Call May 05, 2022, 05:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull - Chief Executive Officer Kevin Herde - Executive Vice President and Chief Financial Officer Conference Call Participants ...
The following slide deck was published by Maravai LifeSciences Holdings, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Maravai LifeSciences Holdings, Inc. 2022 Q1 - Results - Earnings Call Presentation
Maravai LifeSciences (NASDAQ:MRVI) rose 6.3% after a report that the life sciences company is working with a banker after takeover interest. Two U.S. companies are said to be interested in Maravai (MRVI), according to a Betavile "uncooked" alert. Not clear if the bidders will f...
Image source: The Motley Fool. Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) Q1 2022 Earnings Call May 05, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2022 Earn...
Maravai LifeSciences Holdings press release (NASDAQ:MRVI): Q1 Non-GAAP EPS of $0.54 beats by $0.10. Revenue of $244.29M (+64.8% Y/Y) beats by $12M. Outlook: The company continues to project total revenue for 2022 in the range of $920.0 million to $960.0 million, reflecting overall growth of 1...
SAN DIEGO, May 05, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first quarter ended March 31, 2022, toge...
The overall price growth since the inception of IDNA is quite impressive, considering the huge impact of the Covid-19 pandemic in the U.S. equity market. Huge price loss in the past 12 months, but positive price gain in the past three years, is an apparently visible trend in Genomics-...
SAN DIEGO, April 21, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2022 financial and operating results after the market clo...
As Danaher (DHR) is set to kick off the earnings season of the makers of Life Sciences & Diagnostic Tools on Thursday, Bank of America analysts led by Derik de Bruin issued cautious views on the subsector, citing macro and geopolitical headwinds. The earnings season for the group com...
BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY PR Newswire MINNEAPOLIS , April 12, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and Cygnus Technologies, part of Maravai LifeScie...
News, Short Squeeze, Breakout and More Instantly...
Maravai LifeSciences Holdings Inc. Company Name:
MRVI Stock Symbol:
NASDAQ Market:
Maravai LifeSciences Holdings Inc. Website:
2024-07-25 20:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2024 financial and operating results after the market closes on...
- Highlights progress across four priority areas and commitment to environmentally and socially responsible growth. - Conducted first stakeholder assessment to identify and prioritize ESG issues that are most important for Maravai and our stakeholders. - Increased the sc...